RGNX financials
REGENXBIO (RGNX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
RGNX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $170.44M | $150.14M | -$161.20M | -$193.88M | -3.76 |
| 2024 | $83.33M | $49.76M | -$233.35M | -$227.10M | -4.59 |
| 2023 | $90.24M | $53.03M | -$268.13M | -$263.49M | -6.02 |
| 2022 | $112.72M | $58.18M | -$262.88M | -$280.32M | -6.50 |
| 2021 | $470.35M | $418.51M | $159.98M | $127.84M | 2.91 |
| 2020 | $154.57M | $118.85M | -$119.23M | -$111.25M | -2.98 |
- RGNX revenue was $170.44M in fiscal 2025, net income -$193.88M.
Updated 2026-11-05 12:50 UTC